Form 4: Cardinal Health CEO's RSU Grant & Tax Withholding
Insider Transaction Report
Cardinal Health's PSS Segment CEO, Deborah Weitzman, received a grant of restricted share units and had shares withheld for tax obligations related to vested units.
Summary
- Deborah Weitzman, CEO of Cardinal Health's PSS Segment, acquired 10,694 common shares through a restricted share unit (RSU) grant on August 15, 2025.
- These RSUs will vest in three equal annual installments starting August 15, 2026.
- On the same date, 24,128 common shares were disposed of at a price of $150.22 per share to cover tax withholding obligations.
- This tax withholding was related to the vesting of 14,966 RSUs and 39,100 performance share units.
- Following these transactions, Deborah Weitzman directly beneficially owns 74,795 common shares.
Sentiment
Score: 6
Explanation: The filing indicates a routine executive compensation event involving the grant of restricted share units and the subsequent withholding of shares for tax purposes upon vesting of other equity awards. This is a standard practice and does not suggest significant positive or negative operational news.
Positives
- Grant of 10,694 restricted share units (RSUs) to a key executive, aligning management incentives with shareholder interests.
- The RSU grant demonstrates ongoing commitment and compensation for the CEO of the PSS Segment.
Negatives
- Disposal of 24,128 common shares at $150.22 to satisfy tax withholding obligations, reducing the executive's direct beneficial ownership.
Future Outlook
The newly granted restricted share units (RSUs) will vest in three equal annual installments beginning on August 15, 2026, indicating future compensation and retention for the executive.
Industry Context
NA
Related Party Transactions
- Grant of 10,694 restricted share units (RSUs) to Deborah Weitzman, an executive of Cardinal Health.
- Disposal of 24,128 shares by Deborah Weitzman to satisfy tax withholding obligations related to vested RSUs and performance share units.
Stakeholder Impact
- Shareholders: The RSU grant aligns executive incentives with shareholder value creation over the long term. The tax-related share disposal is a routine event and does not indicate a change in company fundamentals.
- Employees: Reflects standard executive compensation practices within the company.
Next Steps
- The granted restricted share units will begin vesting in three equal annual installments starting August 15, 2026.
Key Dates
| Date | Description |
|---|---|
| 08/15/2025 | Date of earliest transaction for RSU grant and share disposal for tax withholding. |
| 08/15/2026 | Start date for the three equal annual installments of RSU vesting. |
| 08/19/2025 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 filing details routine executive compensation activities, specifically the grant of restricted stock units and the sale of shares to cover tax obligations from vested equity. Such transactions are standard and do not typically indicate a change in the company's fundamental performance or outlook. Therefore, it provides no new information to warrant a change in investment stance.
Keywords
Cardinal Health, CAH, Deborah Weitzman, Form 4, SEC filing, insider transaction, restricted share units, RSU, performance share units, tax withholding, executive compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.